Latest Insider Transactions at Okyo Pharma LTD (OKYO)
This section provides a real-time view of insider transactions for Okyo Pharma LTD (OKYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OKYO Pharma Ltd to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OKYO Pharma Ltd's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 27
2023
|
Gabriele M Cerrone Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
70,071
+0.76%
|
$70,071
$1.5 P/Share
|
|
Oct 23
2023
|
Gabriele M Cerrone Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect |
499,468
+5.2%
|
$499,468
$1.5 P/Share
|
|
Sep 15
2023
|
John P Brancaccio Director |
BUY
Open market or private purchase
|
Direct |
16,670
+50.0%
|
$16,670
$1.5 P/Share
|
|
May 19
2022
|
Gabriele M Cerrone Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
5,800,000
+1.05%
|
$0
$0.08 P/Share
|
|
May 19
2022
|
Gabriele M Cerrone Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
37,500
+37.5%
|
$150,000
$4.0 P/Share
|
|
May 19
2022
|
Gary S Jacob Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+50.0%
|
$50,000
$4.0 P/Share
|
|
May 17
2022
|
Gabriele M Cerrone Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
1,625,000
+0.3%
|
$0
$0.06 P/Share
|